Led ARS (€2.75M) and SARAS on autonomous surgical robots; participated in MURAB on MRI/ultrasound robotic biopsy.
UNIVERSITA DEGLI STUDI DI VERONA
Italian university strong in autonomous surgical robotics, neuroinflammation research, and historical linguistics, with high project coordination capacity.
Their core work
The University of Verona is a mid-sized Italian research university with distinctive strength in medical robotics, neuroscience, and historical linguistics. Their biomedical teams develop autonomous surgical robots and study neuroinflammatory mechanisms in Alzheimer's disease, while their humanities scholars lead internationally recognized work on ancient Anatolian and Indo-European languages. They also maintain active research lines in wastewater resource recovery, antimicrobial resistance, and interdisciplinary doctoral training programs.
What they specialise in
Led IMMUNOALZHEIMER (€2.5M ERC) on immune cells in Alzheimer's; recent projects on brain repair, epilepsy, and nanoparticle genotoxicity.
Led PALaC (€1.23M ERC) on pre-classical Anatolian languages and SLUW on Luwian syntax; deep Indo-European expertise.
Participated in SMART-Plant, INTCATCH, ENERWATER, and RES URBIS on phosphorus, bioplastics, and cellulose recovery from wastewater.
Three recent projects with AMR keywords; COVID-19 research activity appearing in second-half keyword profile.
Led INVITE (MSCA-ITN, €1.1M) and coordinated multiple MSCA individual fellowships across disciplines.
How they've shifted over time
In the early H2020 period (2015–2018), Verona's portfolio was split between environmental engineering (wastewater treatment, bioresource recovery), respiratory medicine (lung disease cohorts), and humanities (Luwian linguistics, humanitarian law). From 2019 onward, their focus shifted decisively toward biomedical robotics (autonomous surgery, continuum robotics), antimicrobial resistance, COVID-19 research, and AI-driven health applications. The humanities line matured into well-funded ERC projects on historical linguistics rather than disappearing.
Verona is converging toward AI-assisted medicine — robotic surgery, neuromorphic engineering, and data-driven health — making them a strong partner for future digital health and medical technology consortia.
How they like to work
With 29 of 56 projects as coordinator (52%), Verona leads more often than it follows — unusual for a mid-sized university. They manage both large multi-partner consortia (SMART-Plant, INTCATCH with 10+ partners) and focused ERC/MSCA projects. Their 396 unique partners across 44 countries indicate a hub-style network: they build new consortia rather than repeatedly working with the same circle.
Verona has collaborated with 396 distinct organizations across 44 countries, making it a well-connected hub in the European research landscape. While rooted in Italian and Western European networks, the geographic breadth (including partners like Vilnius) signals openness to pan-European and international collaboration.
What sets them apart
Verona's rare combination of medical robotics, neuroscience, and historical linguistics under one institutional roof creates unusual interdisciplinary potential — few universities can bridge autonomous surgery and ancient language analysis with equal credibility. Their high coordination rate (52%) means they have proven project management capacity, not just scientific input. For consortium builders, this means a partner who can both lead work packages and manage complex multi-country projects.
Highlights from their portfolio
- ARSLargest project (€2.75M, 2017–2023) — led research on fully autonomous robotic surgery, a high-impact convergence of AI and medicine.
- IMMUNOALZHEIMER€2.5M ERC grant (2016–2022) on the immune system's role in Alzheimer's disease — signals deep individual research excellence.
- PALaC€1.23M ERC grant on pre-classical Anatolian language contact — demonstrates Verona's strength in historical linguistics, an unexpected complement to their STEM portfolio.